Purchase Order 75N94022P00148
- Not listed
- This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $19,916.50, is for RNA sequencing services and was awarded to Novogene Corp Inc., a minority-owned small business that specializes in next-generation sequencing and bioinformatics. Novogene has a significant track record of providing genomic services to various federal agencies, including the National...
- Novogene Corp Inc., a minority-owned small business, has been awarded a $13,982 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to provide RNA sequencing services in Bethesda, Maryland. The sequencing will support the agency's biomedical research efforts. As a prime contractor supporting multiple federal agencies, Novogene has over 100 contracts to conduct genomic sequencing and analysis for studies into diseases,...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- The National Institutes of Health's National Institute of Child Health and Human Development (NICHD) awarded a $218,900.00 firm-fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. Novogene has previously received over 100 prime contracts from federal agencies including the Department of Veterans Affairs, Department of Agriculture, and National Oceanic and Atmospheric Administration to provide genomic sequencing and bioinformatics...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
- This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
- This firm fixed-price purchase order in the amount of $72,600.00 was awarded by the National Institute of Child Health and Human Development (NICHD) to Novogene Corporation Inc., a minority-owned small business, for whole exome sequencing services. The award is for an ongoing project focused on identifying new genetic causes of adrenal and pituitary tumors and analyzing the effects of such genetic alterations. The effort involves DNA library preparation, sequencing, and customized bioinformatics...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...
- This is a $24,700 firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian federal agency, to Novogene Corp Inc., a minority-owned small business. The contract does not have a set-aside designation. Novogene specializes in genomic sequencing and bioinformatics services, and has delivered such services to numerous government agencies through various contract vehicles, including a $120,000 Blanket Purchase Agreement with the U.S. Geological Survey...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as a set-aside. Novogene has a significant track record of providing genomic services to various federal agencies, including the NIH, USDA, NOAA, and USGS. The company holds a $120,000 single-award Blanket Purchase Agreement with the USGS for microbial DNA and microRNA sequencing and analysis in support of the agency's earth science research programs. This NICHD contract award is another example of Novogene's ability to support the genomic research needs of the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($954) | 10/9/24 | |
| Not listed | Not listed | $12.7k | 1/21/22 |